Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

ME O'Brien, T Splinter, E.F. Smit, B. Biesma, M Krzakowski, VC Tjan-Heijnen, A Van Bochove, J Stigt, MJ Smid-Geirnaerdt, C. Debruyne, C Legrand, G. Giaccone

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1416-22
JournalEuropean Journal of Cancer
Issue number10
Publication statusPublished - 2003

Cite this